The Henry J. Kaiser Family Foundation (KFF) commissions the National ADAP Monitoring Project and conducts it in partnership with the National Alliance of State and Territorial AIDS Directors (NASTAD) and the AIDS Treatment Data Network (ATDN). The Project seeks to provide timely information on trends and issues that impact state and territorial ADAPs. In addition to its annual report, released in the spring each year, the Project develops issue briefs that allow exploration and analysis of a single topic concerning ADAPs in great depth.
The Annual ADAP Survey, conducted by NASTAD, serves as the basis for the Project's annual report. The survey requests ADAP directors to provide program data including total estimated annual program budget and monthly expenditures, client utilization, and client demographics from June of each year. The resulting data create a snapshot of ADAPs that can be compared over time. KFF, NASTAD, and ATDN analyze the data and co-author the report.This survey and reports, as well as ADAP Watch, are now provided by NASTAD .
The National ADAP Monitoring Report, 2004, the eighth in an annual series, provides an overview of the status of state-administered AIDS Drug Assistance Programs (ADAPs) and documents how these programs are responding to the changing fiscal, clinical and epidemiological dynamics of HIV/AIDS.ADAPs, authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV/AIDS-related prescription drugs to uninsured and underinsured individuals living with HIV/AIDS in the 50 states, the District of Columbia, territories, and associated jurisdictions.
This database provides program information for each ADAPs, including program contacts, financial and medical eligibility criterias, enrollment sites and procedures, covered medications, program restrictions, local CARE consortiums, insurance assistance, and availability of nutritional services.
This issue brief, prepared as part of the National ADAP Monitoring Project, examines ADAP formulary coverage of medications for the prevention and treatment of AIDS-related Opportunistic Infections across states, including trends in coverage and expenditures over time, and discusses some of the potential reasons for variations in coverage.
This report examines how ADAPs purchase and dispense drugs, and the drug discount programs that assist states in containing ADAP costs. The report discusses the federal 340B Program, enacted under the Veterans Health Care Act (VHCA) of 1992, reviews other cost-savings strategies, and examines opportunities for and barriers to ADAPs securing additional discounts.
| To Access Project Home Page ||| To Individual ADAPS ||| To Network Home Page |
| The National Alliance of
State and Territorial AIDS Directors 444 North Capitol Street, NW Suite 339 Washington, DC 20001 Tel: (202) 434-8090 FAX: (202) 434-8092 |
![]() | AIDS
Treatment Data Network The Access Project 611 Broadway Suite 613 New York, NY 10012-2809 Tel: (800) 734-7104 Fax: (212) 260-8869 E-mail: network@atdn.org | |
network@atdn.org copyright © 2002 The Network | |||